EarningsQ1 2024 Earnings Report

Outlook Therapeutics (41O) Q1 2024 Earnings Report

8 Followers

DE:41O Q1 2024 EPS Results

Actual EPS-€0.69

Consensus EPS-€0.86

Beat/MissBeat by +€0.17

One Year Ago EPS-€1.38

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ1 2024

Date02/14/2024

TimeBefore Open

Conference CallWednesday, February 14, 2024

DE:41O Upcoming Earnings

Outlook Therapeutics's next earnings date is estimated for December 18, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Dec 18, 2026	2026 (Q4)	-0.06 / -	-0.052	―
Aug 14, 2026	2026 (Q3)	-0.07 / -0.08	-0.379	79.55% (+0.30)
May 15, 2026	2026 (Q2)	-0.10 / -0.14	-0.345	60.00% (+0.21)
Feb 17, 2026	2026 (Q1)	-0.20 / -0.19	-0.767	75.28% (+0.58)
Dec 19, 2025	2025 (Q4)	-0.22 / -0.05	-0.758	93.18% (+0.71)
Aug 14, 2025	2025 (Q3)	-0.30 / -0.38	-0.715	46.99% (+0.34)
May 15, 2025	2025 (Q2)	-0.47 / -0.34	-1.336	74.19% (+0.99)
Feb 14, 2025	2025 (Q1)	-0.65 / -0.77	-0.689	-11.25% (-0.08)
Dec 27, 2024	2024 (Q4)	-0.69 / -0.76	-0.862	12.00% (+0.10)
Aug 14, 2024	2024 (Q3)	-0.89 / -0.72	-1.379	48.13% (+0.66)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed